The pathophysiology of diabetes is characterized not only by elevated glucose but also elevated long chain fatty acid levels. We show for the first time that the peroxisome proliferatoractivated receptor-␣ (PPAR␣) binds glucose and glucose metabolites with high affinity, resulting in significantly altered PPAR␣ secondary structure. Glucose decreased PPAR␣ interaction with fatty acid metabolites and steroid receptor coactivator-1 while increasing PPAR␣ interaction with DNA. Concomitantly, glucose increased PPAR␣ interaction with steroid receptor coactivator-1, DNA binding, and transactivation of -oxidation pathways in the presence of activating ligands. Heterodimerization of PPAR␣ to the retinoid X receptor-␣ resulted in even larger increases in transactivation with the addition of glucose. These data suggest that PPAR␣ is responsible for maintaining energy homeostasis through a concentration-dependent regulation of both lipids and sugars and that hyperglycemic injury mediated by PPAR␣ occurs not only indirectly through elevated long chain fatty acid levels but also through direct action of glucose on PPAR␣.Energy homeostasis is a highly complex and strictly regulated process. Free fatty acids compete with glucose for oxidation, and increased free fatty acid concentrations are associated with reduced muscle glycogen synthesis. Dysregulation at any step may elicit severe pathophysiological complications, as seen in diabetes. Maintained low levels of blood glucose are critical for preventing or delaying the clinical complications of diabetes, such as insulin resistance and cardiovascular disease (1). Although the liver plays essential roles in the control of blood glucose levels by modulating gluconeogenesis and glycogen synthesis, the specific mechanism(s) of this regulation is unclear. Several studies suggest that peroxisome proliferatoractivated receptor ␣ (PPAR␣), 2 a ligand-regulated transcription factor belonging to the nuclear hormone receptor superfamily, contributes to this regulation. PPAR␣ is highly expressed in liver and is the target of potent hypolipidemic drugs, such as fibrates, used to treat cardiovascular disease (2). Although a variety of compounds bind and activate PPAR␣, long chain fatty acids (LCFA) and their metabolites (i.e. long chain fatty acyl-CoAs, LCFA-CoA) function as high affinity, endogenous ligands (3-5), which could play an important role because diabetes is characterized not only by elevated glucose levels but also elevated LCFA and LCFA-CoA levels (6). Ligand binding initiates PPAR␣ transcription of multiple genes in fatty acid and glucose metabolism while concomitantly down-regulating genes in insulin signaling (7-9). Furthermore, expression of PPAR␣ is elevated in humans with type 2 diabetes (10), and PPAR␣-null mice are protected from high fat diet-induced insulin resistance (11).
EXPERIMENTAL PROCEDURESProtein Expression and Purification-The bacterial expression vector containing murine PPAR␣ (pET-PPAR␣⌬AB) was expressed in the BL21(DE3)pLysS strain of Escherichia coli as de...